Dr. Dalnim Cho, PhD

Claim this profile

M D Anderson Cancer Center

Studies Cancer Survivors
Studies Prostate Cancer
3 reported clinical trials
8 drugs studied

Area of expertise

1Cancer Survivors
Dalnim Cho, PhD has run 2 trials for Cancer Survivors. Some of their research focus areas include:
Stage I
Stage II
Stage III
2Prostate Cancer
Dalnim Cho, PhD has run 2 trials for Prostate Cancer. Some of their research focus areas include:
Stage I
Stage II
Stage III

Affiliated Hospitals

Image of trial facility.
M D Anderson Cancer Center

Clinical Trials Dalnim Cho, PhD is currently running

Image of trial facility.

Culturally Relevant Supportive Care

for Advanced Cancer

To determine the feasibility of implementing a culturally adapted mind-body intervention (Meditation-Based Support-Adapted; MBS-A) as a supportive care strategy in Black patients diagnosed with a stage III-IV solid malignancy. To target the specific needs of Black advanced cancer patients, we will first conduct formative research that includes quantitative surveys and in-depth interviews of patients and their primary caregivers. The purpose of this formative research is to determine the intervention format for the MBS-A program (family- vs group-based) that promises the greatest likelihood of success and to solicit input on the original MBS intervention regarding content that needs adaptation. Once the intervention format is determined and content adapted, we will conduct a pilot randomized controlled trial (RCT) to examine the feasibility of the MBS-A intervention vs. a dose-matched attention control (AC) group receiving a psychoeducation intervention.
Recruiting1 award N/A

More about Dalnim Cho, PhD

Clinical Trial Related5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Dalnim Cho, PhD has experience with
  • Meditation-Based Support-Adapted (MBS-A)
  • Exercise Intervention
  • Informational Intervention
  • Interview
  • Nutritional Assessment
  • Questionnaire Administration
Breakdown of trials Dalnim Cho, PhD has run
Cancer Survivors
Prostate Cancer
Partner
Spouses
Cancer

Other Doctors you might be interested in

Rebecca Harrison, MDBC Cancer - The Vancouver Center
Qian Lu, MDM D Anderson Cancer Center
Lois M RamondettaM D Anderson Cancer Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dalnim Cho, PhD specialize in?
Dalnim Cho, PhD focuses on Cancer Survivors and Prostate Cancer. In particular, much of their work with Cancer Survivors has involved Stage I patients, or patients who are Stage II.
Is Dalnim Cho, PhD currently recruiting for clinical trials?
Yes, Dalnim Cho, PhD is currently recruiting for 1 clinical trial in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Dalnim Cho, PhD has studied deeply?
Yes, Dalnim Cho, PhD has studied treatments such as Meditation-Based Support-Adapted (MBS-A), Exercise Intervention, Informational Intervention.
What is the best way to schedule an appointment with Dalnim Cho, PhD?
Apply for one of the trials that Dalnim Cho, PhD is conducting.
What is the office address of Dalnim Cho, PhD?
The office of Dalnim Cho, PhD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top